Coldstream Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,309 shares of REGN stock, worth $918,721. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,309

Previous 1,249 4.8%

Holding current value

$918,721

Previous $1.31 Million 4.88%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$1024.09 - $1201.76 $61,445 - $72,105	60 Added 4.8%	1,309 $1.38 Million
Q2 2024 Aug 07, 2024	BUY	$883.2 - $1071.19 $57,408 - $69,627	65 Added 5.49%	1,249 $1.31 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $902 - $993	1 Added 0.08%	1,184 $1.14 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $3,100 - $3,526	4 Added 0.34%	1,183 $1.04 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $5,539 - $6,754	8 Added 0.68%	1,179 $970,000
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $23,100 - $27,401	-33 Reduced 2.74%	1,171 $841,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $24,497 - $29,770	36 Added 3.08%	1,204 $989,000
Q4 2022 Jan 10, 2023	BUY	$705.89 - $766.39 $157,413 - $170,904	223 Added 23.6%	1,168 $0
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $212,759 - $286,669	-388 Reduced 40.93%	560 $331,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $211,114 - $284,453	385 Added 68.75%	945 $559,000
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $36,302 - $42,604	61 Added 6.88%	948 $662,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $258,153 - $318,710	475 Added 115.29%	887 $560,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $49,940 - $59,243	-87 Reduced 17.43%	412 $231,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $235,927 - $278,711	499 New	499 $279,000
Q1 2021 Jun 16, 2021	SELL	$446.73 - $548.2 $205,495 - $252,172	-460 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $220,018 - $279,670	460 New	460 $222,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $185,759 - $224,449	-341 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $168,222 - $219,576	341 New	341 $213,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History